Radiochemical purity of routinely prepared 99tcm radiopharmaceuticals: A retrospective study

Nuclear Medicine Communications

Volumn 21, Issue 4, 2000, Pages 349-354

  Decristoforo, C ^a   Siller, R ^a   Chen, F ^a   Riccabona, G ^a  

^a Universitätsklinik für Nuklearmedizin   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TECHNETIUM; TECHNETIUM COMPLEX;

ARTICLE; DRUG CONTAMINATION; HUMAN; ISOLATION AND PURIFICATION; QUALITY CONTROL; RETROSPECTIVE STUDY; STANDARD;

DRUG CONTAMINATION; HUMANS; ORGANOTECHNETIUM COMPOUNDS; QUALITY CONTROL; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM;

EID: 0034169728     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200004000-00009     Document Type: Review

References (35)

1. Monger PN. Recent changes in UK legislation and licensing of radiopharmacies. Nucl Med Commun 1992; 13: 411-415.
2. Kawada T, Wolf W, Seibert S. Planning a radiopharmacy. Am J Hosp Pharm 1974; 13: 153-157.
3. Theobald AE. Quality control of radiopharmaceuticals. In: Sampson CB, ed. Textbook of radiopharmacy: Theory and practice. New York: Gordon & Breach, 1990: 115-148.
4. Frier M, Hesslewood S. Quality assurance of radiopharmaceuticals - a guide to hospital practice. Nucl Med Commun, special issue, 1980.
5. m-sestamibi. Nucl Med Commun 1995; 16: 99-104.
6. m-HMPAO). Nucl Med Commun 1989; 10: 733-740.
7. Carpenter AP. Radioanalytical techniques: ITLC, TLC, mini-columns, and electrophoresis. In: Wieland DM, Tobes MC, Mangner TJ, eds. Analytical and chromatographic techniques in radiopharmaceutical chemistry. New York: Springer, 1986: 261-278
8. Millar AM. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime. Am J Hosp Pharm 1993; 50: 103-106.
9. Hung CY, Corlija M, Volkert WA, Holmes RA. A kinetic analysis of Tc-99m d, l-HMPAO decomposition in aqueous media. J Nucl Med 1988; 19: 1568-1576.
10. Ponto JA. Effect of pertechnetate source and age on the radiochemical purity of technetium Tc 99m exametazime. Am J Hosp Pharm 1990; 47: 2511-2513.
11. Hung JC, Herold TJ, Wilson ME, Bibbons RG. Generator eluate effects on the labelling efficiency of 99mTc-sestamibi. Nucl Med Biol 1995; 22: 949-952.
12. Nosco D, Wolfnagel RG, Bushman M, Grummon G, Marmion M. Technetium-MAG3-labeling conditions and QC. J Nucl Med 1992; 33: 1033-1034.
13. Millar AM, O’Brien LM. An investigation of factors that might influence the radiochemical purity and stability of 99mTc-MAG3. Eur J Nucl Med 1990; 16: 615-619.
14. Hung JC, Thorson LM. Effects of generator eluate age on the radiochemical purity of fractionated 99Tcm-MAG3. Nucl Med Commun 1995; 16: 157-160.
15. Muddukrishna SN, Qi P. Effect of chemical condition of technetium-99m sodium pertechnetate on the active kit components and radiolabeling yield of Tru-Scint AD 99mTc monoclonal antibody kit. J Radioanalyt Nucl Chem 1996; 203: 47-65.
16. Decristoforo C, Chen F, Stöger A, Riccabona G. Failure of labelling of anti-granulocyte antibody. Eur J Nucl Med 1993; 20: 565-566.
17. Millar AM. A multicenter evaluation of techniques for determination of the radiochemical purity of Tc-99m DTPA. In: Cox PH, Mather SJ, Sampson CB, Lazarus CR, eds. Progress in radiopharmacy. Boston, MA: Martinus-Nijhoff, 1986: 327-337.
18. Bonnyman J, Ivanov Z, Lauder R. Results of the quality assurance testing programme for radiopharmaceuticals 1986. Report of the Australian Radiation Laboratory, Melbourne, Victoria, Australia, 1989: 32.
19. Schomacker K, Gerad H, Gabruk-Szostak B, Schicha H, Malja S. Verschiedene 99mTc-Generatoreluate: Auswirkungen auf die radiochemische Reinheit der Markierungsprodukte. Nuklearmedizin 1994; 33: 33-39.
20. Decristoforo C, Chen F, Riccabona G. Qualitätskontrolle von Radiopharmaka in der Klinik - eine Notwendigkeit? Nuklearmedizin 1993; 32: 144-148.
21. Ponto JA. Technetium-99m radiopharmaceutical preparation problems: 12 years of experience. J Nucl Med Technol 1998; 26: 262-264.
22. Decristoforo C, Zaknun J, Kohler B, Oberladstaetter M, Riccabona G. The use of electronic autoradiography in radiopharmacy. Nucl Med Biol 1997; 24: 361-365.
23. Decristoforo C, Riccabona G. Problems with fractionated cold-kits. J Nucl Med 1996; 37: 1912-1913.
24. Steigman J, Eckelman WC. The chemistry of technetium in medicine. Nuclear Science Series. Washington, DC: National Acadamy Press, 1992.
25. Solanki C, Li DJ, Barber RW, Wraight EP, Sampson CB. Stabilization and multidose use of exametazime for cerebral perfusion studies. Nucl Med Commun 1994; 15: 718-722.
26. Chowhury S, Hung JC. Reconstitution and fractionation of Cardiolite kit into multidose cold kits for cost saving (abstract). J Nucl Med 1995; 36(suppl.): 80P.
27. Thorson LM, Hung JC, Hollar BS. Feasibility of fractionating MAG3 cold kit for cost reduction. Nucl Med Commun 1992; 13: 832-837.
28. Ballinger JR, Golan H, Ichise M. Cost effective preparation of Tc-99m ECD by freezing excess ligand (abstract). J Nucl Med 1995; 36(suppl.): 80P.
29. Decristoforo C, Obendorf D, Reichart E, Stubauer G, Riccabona G. Determination of Sn(II) in technetium cold kits by voltammetry at the hanging mercury drop electrode (HMDE) and relevant radiopharmaceutical applications. Nucl Med Biol 1998; 25: 675-681.
30. Lazarus C, Palmer AM, Hesslewood SR. Radiopharmaceutical kit modification (editorial). Nucl Med Commun 1998; 19: 613-614.
31. Ricordel I, Bussy E. De la necessite du controle radiopharmaceutique et d’une radiopharmaco-surveillance. Ann Pharm Fr 1995; 53: 8-12.
32. Cox JA, Hesslewood SR, Palmer AM. A mechanism for professional and organizational audit of radiopharmacy departments. Nucl Med Commun 1994; 15: 890-898.
33. British Institute of Radiology. Guidelines for the preparation of radiopharmaceuticals in hospitals. Special Report No. 11. London: BIR, 1975.
34. Nordic Guidelines. Radiopharmacy, preparation and control of radiopharmaceuticals in hospitals. NLN Publication No. 26. Uppsala: Nordic Council on Medicines, 1989.
35. Reske SN, Brandau W, Coenen HH et al. Radioaktive Arzneimittel und § 73 AMG. Nuklearmedizin 1989; 28: 208-214.